Regencell Bioscience Holdings Ltd Cash Flow-to-Debt Ratio
Regencell Bioscience Holdings Ltd cash flow-to-debt ratio. Regencell Bioscience Holdings Ltd (RGC) has a Cash Flow-to-Debt Ratio of -1.44x as of March 2026, meaning its operating cash flow of $-2.59 Million could theoretically repay -1% of its total liabilities ($1.79 Million) in one year. Check RGC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Regencell Bioscience Holdings Ltd (2003–2025)
Cash flow-to-debt ratio of Regencell Bioscience Holdings Ltd from 2003 to 2025. Historical debt coverage capacity for Regencell Bioscience Holdings Ltd across 23 annual periods. Check Regencell Bioscience Holdings Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Regencell Bioscience Holdings Ltd Cash Flow-to-Debt Ratio by Year (2003–2025)
Regencell Bioscience Holdings Ltd cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Regencell Bioscience Holdings Ltd. For the full cash flow conversion analysis, see Regencell Bioscience Holdings Ltd (RGC) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.48x | $-3.11 Million | $895.31K | ▲ +80.9% |
| 2024 | -18.23x | $-4.00 Million | $219.51K | ▼ -132.3% |
| 2023 | -7.85x | $-4.96 Million | $632.32K | ▼ -39.8% |
| 2022 | -5.62x | $-5.27 Million | $938.03K | ▼ -3074.3% |
| 2021 | -0.18x | $-767.31K | $4.34 Million | ▲ +22.9% |
| 2020 | -0.23x | $-726.57K | $3.16 Million | ▼ -22.2% |
| 2019 | -0.19x | $-390.99K | $2.08 Million | ▼ -269.5% |
| 2018 | 0.11x | $409.90 Million | $3.70 Billion | ▼ -5.9% |
| 2017 | 0.12x | $410.50 Million | $3.48 Billion | ▼ -4.8% |
| 2016 | 0.12x | $434.40 Million | $3.51 Billion | ▲ +21.8% |
| 2015 | 0.10x | $349.10 Million | $3.43 Billion | ▲ +0.2% |
| 2014 | 0.10x | $346.90 Million | $3.42 Billion | ▼ -14.9% |
| 2013 | 0.12x | $346.60 Million | $2.91 Billion | ▼ -1.6% |
| 2012 | 0.12x | $353.10 Million | $2.91 Billion | ▲ +39.4% |
| 2011 | 0.09x | $259.40 Million | $2.98 Billion | ▼ -38.9% |
| 2010 | 0.14x | $410.80 Million | $2.88 Billion | ▲ +49.8% |
| 2009 | 0.10x | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $1.04 Billion | — |